ENDY Stock Overview
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Endymed Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪3.25 |
| 52 Week High | ₪4.44 |
| 52 Week Low | ₪2.79 |
| Beta | -0.22 |
| 1 Month Change | -1.81% |
| 3 Month Change | 7.62% |
| 1 Year Change | 12.26% |
| 3 Year Change | 16.07% |
| 5 Year Change | -1.66% |
| Change since IPO | -50.61% |
Recent News & Updates
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up
Mar 11
Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital
Oct 23Recent updates
Endymed Ltd's (TLV:ENDY) Share Price Not Quite Adding Up
Mar 11Endymed (TLV:ENDY) Is Looking To Continue Growing Its Returns On Capital
Oct 23We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jul 17Returns Are Gaining Momentum At Endymed (TLV:ENDY)
Apr 03Endymed's (TLV:ENDY) Returns On Capital Are Heading Higher
Nov 18We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Jun 03Endymed (TLV:ENDY) Is Doing The Right Things To Multiply Its Share Price
Feb 13Here's Why We Think Endymed (TLV:ENDY) Is Well Worth Watching
Nov 28Endymed (TLV:ENDY) Is Experiencing Growth In Returns On Capital
Oct 31Is Now The Time To Put Endymed (TLV:ENDY) On Your Watchlist?
Aug 29Investors Will Want Endymed's (TLV:ENDY) Growth In ROCE To Persist
Aug 01We Like These Underlying Return On Capital Trends At Endymed (TLV:ENDY)
Apr 11Endymed Ltd's (TLV:ENDY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Feb 15Returns On Capital - An Important Metric For Endymed (TLV:ENDY)
Jan 10Should You Use Endymed's (TLV:ENDY) Statutory Earnings To Analyse It?
Dec 14
Shareholder Returns
| ENDY | IL Medical Equipment | IL Market | |
|---|---|---|---|
| 7D | 0.03% | -0.3% | 2.9% |
| 1Y | 12.3% | 6.3% | 10.8% |
Return vs Industry: ENDY exceeded the IL Medical Equipment industry which returned 6.3% over the past year.
Return vs Market: ENDY exceeded the IL Market which returned 10.8% over the past year.
Price Volatility
| ENDY volatility | |
|---|---|
| ENDY Average Weekly Movement | 6.8% |
| Medical Equipment Industry Average Movement | 4.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.3% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: ENDY has not had significant price volatility in the past 3 months.
Volatility Over Time: ENDY's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 46 | Yossi Bar-On | www.endymed.com |
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 and is based in Freehold, New Jersey.
Endymed Ltd Fundamentals Summary
| ENDY fundamental statistics | |
|---|---|
| Market cap | ₪44.73m |
| Earnings (TTM) | ₪2.10m |
| Revenue (TTM) | ₪86.47m |
21.3x
P/E Ratio0.5x
P/S RatioIs ENDY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENDY income statement (TTM) | |
|---|---|
| Revenue | US$22.78m |
| Cost of Revenue | US$11.23m |
| Gross Profit | US$11.55m |
| Other Expenses | US$11.00m |
| Earnings | US$553.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.04 |
| Gross Margin | 50.71% |
| Net Profit Margin | 2.43% |
| Debt/Equity Ratio | 0% |
How did ENDY perform over the long term?
See historical performance and comparison